Search Medical Condition
Please enter condition
Please choose location
 

Haikou, China Clinical Trials

A listing of Haikou, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (26) clinical trials

TAK-491 (Azilsartan Medoxomil) Compared to Valsartan in Chinese Participants With Hypertension

The drug being tested in this study is called TAK-491 (azilsartan medoxomil). Azilsartan medoxomil is being tested to treat Chinese people who have essential hypertension. This study will look at change in blood pressure after 8 weeks of treatment in people who take azilsartan medoxomil compared to people who take ...

Phase

0.0 miles

Learn More »

Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia

This is a randomized, double-blind, multicenter, placebo-controlled trial to compare the efficacy and safety of pregabalin SR vs placebo in patients with PHN. The study is conducting at 27 study centers in China. Patients were randomized to receive pregabalin, starting at 165 mg/day and increasing to a maintenance dose of ...

Phase

0.0 miles

Learn More »

A Study of Arterial Vasculature Below the Knee Treated With LEGFLOW OTW

To evaluate the safety and efficacy of the paclitaxel-eluting peripheral balloon dilatation catheter (LEGFLOW) compare to the PTA catheter (AMPHIRION DEEP).in treatment of stenosis or occlusion in in arterial vasculature below the knee. This is a prospective, multi-center, randomized, control, opening, superiority designed clinical study. Plan to enroll 172 eligible ...

Phase N/A

0.0 miles

Learn More »

The Femoral Popliteal Artery Trial for LEGFLOW OTW

To evaluate the safety and efficacy of the paclitaxel eluting balloon dilatation catheter (LEGFLOW OTW) compared with the standard balloon (Admiral Xtreme) for the treatment of stenosis or occlusions in femoral popliteal artery. This is a prospective, multicenter, prior desiged, randomize and controlled study, planned to enrol 172 subjects. all ...

Phase N/A

0.0 miles

Learn More »

Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population

Edwards SAPIEN XT™ Transcatheter Heart Valve and NovaFlex+ delivery system will be used for this study. A maximum of 60 patients with symptomatic severe calcific aortic stenosis requiring transcatheter aortic valve implantation (TAVI), who are considered high risk for surgical valve replacement who receive a SAPIEN XT THV.

Phase N/A

0.0 miles

Learn More »

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Oversight Authorities continued: Colombia- pending regulatory approval

Phase

5.63 miles

Learn More »